Positron emission tomography with the deoxyglucose technique and the diagnosis of Alzheimer's disease Academic Article Article uri icon

Overview

MeSH Major

  • Alzheimer Disease
  • Amyloid beta-Peptides
  • Hippocampus
  • tau Proteins

abstract

  • Riege and Metter provide a useful review of the application of PET in the evaluation of Alzheimer's disease (AD). We share their enthusiasm for continued support and development of tools to image metabolic processes. Our commentary focuses on neuroimaging and the diagnosis of AD and introduces some new data that directly impacts on the interpretation of PET-2-deoxyglucose (2DG) data. © 1988 Pergamon Journals Ltd.

publication date

  • January 1988

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0197-4580(88)80029-0

PubMed ID

  • 3260012

Additional Document Info

start page

  • 88

end page

  • 90

volume

  • 9

number

  • C